Medicure Inc.
MPH.V
TSX
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -0.57% | -8.82% | -10.81% | -7.06% | -9.26% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -0.57% | -8.82% | -10.81% | -7.06% | -9.26% |
| Cost of Revenue | 16.40% | 33.35% | 18.40% | 9.25% | 6.16% |
| Gross Profit | -9.89% | -27.17% | -23.35% | -14.41% | -15.97% |
| SG&A Expenses | 0.95% | 2.91% | 4.35% | 2.96% | -1.18% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 8.92% | 14.80% | 10.62% | 2.56% | -0.68% |
| Operating Income | -254.36% | -447.45% | -244.63% | -270.31% | -168.68% |
| Income Before Tax | 13.91% | -270.22% | -213.04% | -194.96% | -162.27% |
| Income Tax Expenses | 875.79% | 98.29% | 25.88% | 420.00% | 15.15% |
| Earnings from Continuing Operations | -11.23% | -286.40% | -221.16% | -197.95% | -165.10% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -11.23% | -286.40% | -221.16% | -197.95% | -165.10% |
| EBIT | -254.36% | -447.45% | -244.63% | -270.31% | -168.68% |
| EBITDA | -246.21% | -184.02% | -132.64% | -90.14% | -70.86% |
| EPS Basic | -11.68% | -284.50% | -219.40% | -196.45% | -163.75% |
| Normalized Basic EPS | -227.44% | -469.28% | -247.61% | -269.72% | -181.42% |
| EPS Diluted | -10.25% | -302.09% | -225.49% | -203.05% | -168.46% |
| Normalized Diluted EPS | -223.29% | -475.47% | -249.94% | -275.71% | -184.76% |
| Average Basic Shares Outstanding | 0.34% | 0.78% | 1.24% | 1.69% | 1.46% |
| Average Diluted Shares Outstanding | -2.98% | -2.98% | 3.07% | 3.83% | 3.68% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |